Related references
Note: Only part of the references are listed.Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes
Mitsunori Miyazaki et al.
FEBS JOURNAL (2010)
High-frequency electrically stimulated skeletal muscle contractions increase p70s6k phosphorylation independent of known IGF-I sensitive signaling pathways
Sarah Witkowski et al.
FEBS LETTERS (2010)
A Phosphatidylinositol 3-Kinase/Protein Kinase B-independent Activation of Mammalian Target of Rapamycin Signaling Is Sufficient to Induce Skeletal Muscle Hypertrophy
Craig A. Goodman et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch
Mitsunori Miyazaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
COX-2 inhibitor reduces skeletal muscle hypertrophy in mice
Margaret L. Novak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Changes in muscle mass with mechanical load: possible cellular mechanisms
Espen E. Spangenburg
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2009)
Serum IGF-I-Deficiency Does Not Prevent Compensatory Skeletal Muscle Hypertrophy in Resistance Exercise
Wayne Matheny et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals
Mitsunori Miyazaki et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis
Micah J. Drummond et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions
T. K. O'Neil et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
Jingxiang Huang et al.
BIOCHEMICAL JOURNAL (2008)
Involvement of the ERK1/2 MAPK pathway in insulin-induced S6K1 activation in avian cells
Sophie Duchene et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2008)
A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy
Espen E. Spangenburg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
The RSK family of kinases: emerging roles in cellular signalling
Rana Anjum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase-mediated mTOR activation in tuberous sclerosis and human cancer
Li Ma et al.
CANCER RESEARCH (2007)
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
Robert A. Frost et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation
Philippe P. Roux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy
John J. McCarthy et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
Li Ma et al.
CELL (2006)
mTOR function in skeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators
GA Nader et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Skeletal muscle hypertrophy and atrophy signaling pathways
DJ Glass
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure
R Hambrecht et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2005)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
L Ma et al.
CELL (2005)
Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bε mRNA in a mammalian target of rapamycin-dependent manner
N Kubica et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors
BA Ballif et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
S6K1-/-/S6K2-/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway
M Pende et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism
TA Hornberger et al.
BIOCHEMICAL JOURNAL (2004)
Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy
KMV Lai et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
TOR signalling in bugs, brain and brawn
E Jacinto et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
GSK-3β negatively regulates skeletal myotube hypertrophy
DR Vyas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
C Rommel et al.
NATURE CELL BIOLOGY (2001)